ARCHIVES

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

This article is from The Cancer Letter archive.

Vol. 17 No. 44 | November 15, 1991

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

March 12, 2004

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

December 31, 2004

Emil Frei, Pioneer of Combination Chemotherapy, Dies at 89

May 10, 2013

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

Health Care Delivery: Value Of Informatics To PPMs Is a Message for Academic Centers

November 22, 1996